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Abstract
Purpose: Perineural invasion (PNI) by cancer cells is an ominous clinical event that is associated with increased local
recurrence and poor prognosis. Although radiation therapy (RT) may be delivered along the course of an invaded nerve, the
mechanisms through which radiation may potentially control PNI remain undefined.
Experimental Design: An in vitro co-culture system of dorsal root ganglia (DRG) and pancreatic cancer cells was used as a
model of PNI. An in vivo murine sciatic nerve model was used to study how RT to nerve or cancer affects nerve invasion by
cancer.
Results: Cancer cell invasion of the DRG was partially dependent on DRG secretion of glial-derived neurotrophic factor
(GDNF). A single 4 Gy dose of radiation to the DRG alone, cultured with non-radiated cancer cells, significantly inhibited PNI
and was associated with decreased GDNF secretion but intact DRG viability. Radiation of cancer cells alone, co-cultured with
non-radiated nerves, inhibited PNI through predominantly compromised cancer cell viability. In a murine model of PNI, a
single 8 Gy dose of radiation to the sciatic nerve prior to implantation of non-radiated cancer cells resulted in decreased
GDNF expression, decreased PNI by imaging and histology, and preservation of sciatic nerve motor function.
Conclusions: Radiation may impair PNI through not only direct effects on cancer cell viability, but also an independent
interruption of paracrine mechanisms underlying PNI. RT modulation of the nerve microenvironment may decrease PNI, and
hold significant therapeutic implications for RT dosing and field design for patients with cancers exhibiting PNI.
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Introduction
Perineural invasion (PNI) has been broadly defined as tumor
cell invasion, in, around and through nerves [1]. PNI is a frequent
clinical and pathological finding in head and neck, pancreatic,
prostate, and other cancers [2], and has been shown to be a
marker of poor outcome, with increased locoregional recurrence
rates and decreased survival [3–5]. Support for the clinical
application of radiation therapy (RT) in the treatment of cancers
with PNI is derived primarily from limited retrospective series
demonstrating improved local control rates following radiation of
neurotrophic cancers [6–9]. However, we currently lack a
biological understanding of how radiation treatment of PNI
translates into improved disease control. In current head and neck
cancer clinical practice, full therapeutic doses of radiation may be
applied to cranial nerves exhibiting PNI along the entire course of
the nerve to the skull base. A mechanistic justification for such
clinical practice, however, is lacking.
Early theories on PNI suggested that its pathogenesis was
centered on neural sheaths serving as a low-resistance conduit for
tumor cell growth, or through lymphatic channels [10,11]. More
recent studies have suggested that PNI involves signaling amongst
tumor, nerve, and stromal cells through paracrine mechanisms
[12,13]. Neurotrophic and axonal guidance molecules have potent
effects on axonal growth, and may be upregulated in cancers with
a predilection for nerve invasion [14–16]. Neurotrophic factors
secreted in a gradient along nerves [17] may play a pivotal role in
PNI pathogenesis. Our group recently demonstrated that nerve
secretion of glial-derived growth factor (GDNF) activates RET-
receptor mediated cancer cell chemotaxis, guiding directional cell
migration towards and along nerves [18].
In the current study, we examine how RT may mechanistically
inhibit PNI in the context of this new paradigm, emphasizing the
importance of considering the dynamic interactions occurring
between cancer cells and the nerve microenvironment. We
hypothesized that RT may impair PNI through both direct effects
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39925on cancer cell viability, and also by potentially altering the nerve
microenvironment through a disruption of neurotrophic gradients.
This approach was based on powerful in vitro and in vivo models of
PNI that permit the study of interactions between cancer cells and
nerve.
Materials and Methods
Ethics statement
All mouse studies were performed in accordance with institu-
tional protocol guidelines at Memorial Sloan-Kettering Cancer
Center (MSKCC). Mice were maintained according to NIH
Animal Care guidelines, under protocols approved by the
MSKCC Institutional Animal Care Committee describing exper-
iments specific to this study (protocol number 05-04-006). Studies
on human tissue samples were approved by the MSKCC
Institutional Review Board. Written informed consent was
received from all participants.
Cell lines, reagents, antibodies
Human pancreatic adenocarcinoma (MiaPaCa2) and head and
neck squamous cell carcinoma (QLL2) cell lines were used.
MiaPaCa2 was purchased from the American Type Culture
Collection (Manassas, VA). QLL2 was derived from a patient at
Memorial Sloan-Kettering Cancer Center (MSKCC) [19]. Cells
were grown in vitro in Dulbecco’s modified Eagle medium
(DMEM) containing 10% fetal calf serum (FCS), penicillin, and
streptomycin, and incubated in 5% CO2-humidified incubator at
37uC. GDNF was obtained from EMD Chemicals (Rockland,
MA). Anti-GDNF antibody (5 mg/mL) was obtained from Abcam
(Cambridge, MA).
Colony forming assays
MiaPaCa2 were irradiated in single-fraction doses between 2
and 10 Gy. Cells ranging from 1610
2 to 5610
3 were plated, and
colonies were stained with cresyl violet and counted 8 days later.
Results are expressed as surviving fraction accounting for plating
efficiency. All experiments were performed in triplicate.
Figure 1. GDNF-mediated cancer cell migration and a DRG co-culture model of PNI. A. MiaPaCa2 pancreatic cancer cells were (**) grown in
a culture insert adjacent to a DRG (*) in Matrigel. Bar, 500 mm. DRG becomes invaded by MiaPaCa2 (arrow) which track along a neurite. Bar, 250 mm.
Area of invasion was calculated using Metamorph computer software, 8 days after insert removal. Bar, 50 mm. B. MiaPaCa2 reliably invades DRG, in
contrast to the squamous cell carcinoma cell line QLL2 ({ p,0.05, t-test). C. MiaPaCa2 migrate towards both GDNF and DRG in Boyden chamber
assays. D. DRG treated with anti-GDNF antibodies demonstrated decreased area of invasion by MiaPaCa2 (p=0.15, t-test). Photomicrographs show
representative decreased area of invasion (arrow) at day 8 with anti-GDNF antibody treatment in comparison to control. Bar, 250 mm.
doi:10.1371/journal.pone.0039925.g001
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Polyethylene terephthalate 8.0 mm pore inserts (BD Biosciences,
Bedford, MA) were used in 24-well plates. Cancer cells were
incubated in 0.1% FCS media overnight, and 2610
5 cells were
added to each insert in 0.5 mL of media with 0.1% FCS. Dorsal
root ganglia (DRG) from newborn male Balb/c mice were isolated
as previously described [18,20]. Below the inserts, 0.7 mL of 0.1%
FCS media was added to each of the wells with GDNF (100 ng/
mL), DRG, or DRG radiated by single doses up to 16 Gy. The
inserts were removed after 24 hours, and non-migrating cells
wiped off with a cotton swab. The migrating cells on the
undersurface of the membrane were fixed in 100% alcohol and
stained with 1% methylene blue in 1% borax. Membranes were
excised and mounted on glass slides. Cells were counted at five
high-power fields at predetermined areas of the membrane.
In vitro co-culture model of nerve invasion
Excised DRG were implanted in growth factor–depleted
Matrigel matrix (BD Biosciences Bedford, MA) adjacent to a cell
culture insert containing a divider (Ibidi, Munchen, Germany). At
day 5 after DRG explantation, 1610
4 cancer cells were added to
the insert and the divider was removed 24 hours later to permit a
controlled starting point for the onset of interactions. The area of
invasion into the DRG was calculated 8 days following culture
insert removal using software (MetaMorph 7.7.4; Molecular
Devices, Sunnyvale, CA) to outline the area invaded by cancer
cells. Images were acquired on an Axiovert 200M microscope
(Carl Zeiss, Oberkochen, Germany) using a Photometrics Cool-
snap ES camera (Photometrics, Tucson, AZ).
For studies blocking GDNF, anti-GDNF antibody (5 mG/mL)
was added to media every other day, with goat immunoglobulin G
used as control. For studies using RT, single fraction doses of
radiation were administered to either cancer cells or DRG using a
Figure 2. Radiation to DRG alone impairs PNI in vitro. A. DRG (*) remained viable without morphological change after a single dose of 16 Gy;
however, a single dose of 24 Gy results in a loss of neurites (arrows) consistent with DRG death. Bar, 500 mm. B. DRG co-culture model of PNI was
performed. Non-radiated MiaPaCa2 cells were grown in an insert adjacent to a DRG exposed to a single dose of radiation (4–16 Gy) in Matrigel. The
insert was removed, and 8 days later the area of invasion was calculated using Metamorph computer software. Low doses of radiation to the DRG
significantly suppressed invasion by untreated cancer cells ({ p,0.05, t-test). A photomicrograph of a DRG (*) 8 days after exposure to 4 Gy shows no
PNI, in contrast to control, non-radiated DRG (area of invasion outlined). Bar, 250 mm. C. GDNF ELISA was performed on conditioned media from DRG
8 days after a single radiation exposure. Single doses of radiation as low as 4 Gy suppressed GDNF to levels below the limit of detection (31 pg/mL).
D. GDNF supplementation partially rescues invasion following RT. DRG were grown in Matrigel supplemented with GDNF (150 ng) and then radiated
to 4 Gy. GDNF was added (60 ng) to the DRG every other day, which partially restored the mean area of invasion (p,0.05, t-test).
doi:10.1371/journal.pone.0039925.g002
Radiation Impairs Perineural Invasion
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e39925Shepard Mark-1 Cs-137 irradiator. Radiated cancer cells were
added to inserts twenty-four hours after radiation. Non-radiated
cancer cells were added to radiated DRG 24 hours after radiation.
For GDNF rescue experiments, DRG were explanted and grown
in Matrigel with GDNF (150 ng) for 5 days, and then radiated to 4
Gy. After cancer cells were added to the insert, GDNF (60 ng) was
added into the Matrigel drop every other day. Phosphate-buffered
saline (PBS) added to the non-radiated DRG served as controls.
In vivo model of murine sciatic nerve invasion
Radiation was administered to selected nude athymic mice
using an X-RAD 320 animal irradiator (Precision X-Ray, North
Branford, CT). Mice were given ketamine (1.5 mg/mL) prior to
radiation. Single-fraction doses up to 16 Gy were administered
along the entire course of the sciatic nerve up to the spinal cord
utilizing a custom lead shield (Precision X-Ray, North Branford,
CT).
One week after radiation to the sciatic nerve, mice were
anesthetized using isoflurane (5% for induction, 2% for mainte-
nance), and their sciatic nerves were surgically exposed. The nerve
was identified deep to the femerococcygeous and biceps femoris
muscles. MiaPaCa2 cells were microscopically injected into the
distal sciatic nerve under the epineurium. Microinjection of 3 mL
of cell suspension at a concentration of 2610
5 cells/mL was
performed using a custom-made Hamilton syringe.
Sciatic nerve function was measured weekly as described
previously, utilizing gross behavior, sciatic neurological score
(hind limb motor response to extension, 4=normal and 1=full
paralysis) and sciatic nerve function index (hindpaw width) [18].
Sciatic nerve specimens were excised immediately following
Figure 3. Radiation of MiaPaCa2 cells impairs migration and PNI predominantly through compromised cellular viability. A. Colony-
forming assays of MiaPaCa2 cells show susceptibility to single-fraction radiation doses, with logarithmically diminishing surviving fractions up
through 8 Gy. B. MiaPaCa2 cells were radiated at varying single fraction doses, 24 hours later serum starved overnight, and then added (2610
5) to the
upper chamber of migration assays. The lower chamber contained control media, DRG, or GDNF (100 ng/mL). Radiation reduced the number of
migrating cells towards DRG or GDNF in a dose-dependent fashion. MiaPaCa2 were radiated and simultaneously plated with migration assays, under
identical conditions, and counted after 24 hours. Dose-dependent decreases in cancer cell number, attributable to radiation induced cell death,
correlated with results from migration assay. C. Single fraction doses of radiation (2–8 Gy) were applied to MiaPaCa2 cells prior to their addition to the
DRG co-culture model of PNI. Radiation doses as low as 2 Gy significantly decreased the area of invasion ({ p,0.05, t-test). MiaPaCa2 were radiated
and simultaneously plated with DRG co-culture assays, under identical conditions, and counted after 8 days. Dose-dependent decreases in cancer cell
number, attributable to radiation induced compromised cell viability, correlated with decreases in area of invasion. D. MiaPaCa2 colonies adjacentt o
the DRG (*) at day 8 show diminished viability with increasing radiation dose, consistent with cell numbers quantified in Fig. 3C. White bar, 1000 mm,
black bar, 250 mm.
doi:10.1371/journal.pone.0039925.g003
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on glass slides. The slides were fixed and stained with hematoxylin
and eosin and reviewed with a pathologist (E. Vakiani). Images
were acquired with a Mirax slide scanner (20x/0.8 NA objective)
utilizing Mirax scan software (Carl Zeiss, Oberkochen, Germany).
GDNF production by DRG and sciatic nerves
Normal or radiated DRG were grown in 24-well plates for
13 days and the conditioned media removed and centrifuged.
Supernatant was assayed for GDNF using an enzyme-linked
immunosorbent assay (ELISA) kit (GDNF EmaxH ImmunoAssay
System, Promega, Madison, WI).
A single-fraction dose of 8 Gy was administered to the right
sciatic nerve as described, with the non-radiated left nerve serving
as control. Three weeks following radiation, mice were sacrificed
and bilateral sciatic nerves were excised. Identical segments of
nerve were removed. The nerves underwent homogenization with
an electronic pestle grinder (Fisher Scientific, Pittsburgh, PA).
Tissue lysates were centrifuged and analyzed by GDNF ELISA.
Total protein was quantified for each nerve (Bio-Rad, Hercules,
CA).
MRI of sciatic nerves
Mice were subjected to magnetic resonance imaging (MRI),
performed on a Bruker USR 4.7T 40-cm bore scanner (Bruker
Biospin MRI GmbH, Ettlingen, Germany) equipped with a
400 mT/m 12-cm bore gradient, using a custom-designed active
decoupled radiofrequency surface coil (Stark MRI Contrast
Research, Erlangen, Germany). Mice were anesthetized with 1%
to 1.5% Isoflurane (Baxter Healthcare Corp., Deerfield, IL) in
oxygen and monitored with an animal physiological monitoring
system (SA Instruments Inc., Stony Brook, NY). A scout fast spin
echo scan in three orientations was acquired to localize the sciatic
nerve, followed by an oblique-coronal T2-weighted fast spin-echo
image acquired with: TR/TE 1.9 s and 40 ms, 1176186 mm in-
plane resolution, 20 slices of 0.8 mm slice thickness and 16
averages. Contrast was injected via mouse tail vein 0.1 mmol/kg
Gd-DTPA (gadolinium diethylenetriamine penta-acetic acid),
Magnevist (Bayer Healthcare Pharmaceuticals Inc., Wayne, NJ).
Figure 4. PNI in vivo is impaired following radiation. A. Untreated MiaPaCa2 cells were implanted into the distal sciatic nerve of mice under
anesthesia. Nine weeks later, there is gross thickening along the course of the nerve, consistent with PNI in comparison to a normal sciatic nerve. B.
MRI (T2 weighted image) and hematoxylin and eosin (H&E) staining of a mouse injected with PBS into the sciatic nerve respectively show a thin,
barely visible, sciatic nerve (bar, 1.0 cm) with normal nerve histology (bar, 100 mm). MRI and H&E of a non-radiated mouse after injection with non-
radiated MiaPaCa2 cells respectively demonstrate a thick and enhancing right sciatic nerve extending toward the spine cord and extensive invasion
of the nerve. MRI and H&E of a mouse radiated to 4 Gy to the sciatic nerve only, respectively show decreased nerve thickness and PNI, as compared
with control. MRI and H&E after injection of a non-radiated mouse with MiaPaCa2 cells radiated to 4 Gy respectively show decreased nerve thickness
and PNI as compared with control.
doi:10.1371/journal.pone.0039925.g004
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quired continuously prior to and after injection. The acquisition
parameters were TR 126 ms, TE 2.2 ms, 1566186 mm in-plane
resolution, 12 slices with 0.8 mm slice thickness, 8 averages with a
time resolution of 3 minutes.
RET expression by human adenoid cystic carcinoma
Previously untreated patients with adenoid cystic carcinoma
(ACC) were identified through a search of the MSKCC Pathology
Tissue Bank. Primary tumor paraffin embedded tissue blocks were
obtained. Hematoxylin and eosin stained slides were evaluated for
the presence of nerve invasion by an experienced pathologist (E.
Vakiani). Sections were cut at 5 mm thickness from paraffin blocks.
Immunostaining for RET was performed with a Ventana
automated staining system (Ventana Medical Systems, Tucson,
AZ) and a polyclonal pig anti-human RET antibody (Abgent, San
Diego, CA). A purified human medullary carcinoma cell line (TT)
expressing RET was used as the positive control, and a purified
fibroblast cell line pellet lacking RET was used as the negative
control. Images of slides were captured on an Olympus BX 41
microscope using an Olympus DP20 camera (Olympus, Center
Valley, PA).
Statistical analyses
A student t-test was used for statistical analysis as appropriate.
All P values were calculated using two-sided tests. Differences were
considered statistically significant if P was less than .05. Error bars
in the graphs represent 95% confidence intervals. Data from
representative experiments are shown.
Figure 5. Radiation to the sciatic nerve alone impairs PNI and preserves nerve function in vivo. A. Representative images of a mouse
injected with PBS into the right sciatic nerve demonstrate normal bilateral hind limb function and a normal sciatic nerve in situ. Representative
images of a mouse 7 weeks after injection of MiaPaCa2 into the right sciatic nerve demonstrate paralysis of the right hind limb and gross tumor (*)
with PNI and sciatic nerve thickening (arrow) in situ. Representative images of a mouse that received 8 Gy of radiation to the right sciatic nerve which
was then injected with non-radiated MiaPaCa2 cells. Seven weeks later, right hind limb function remains intact and a smaller gross tumor (*) with no
sciatic nerve thickening (arrow) in situ. B. Radiation to the sciatic nerve, prior to cancer injection, preserves hind limb function. Mean right sciatic nerve
function score of mice receiving 0 (control) or 8 Gy to the right sciatic nerve prior to injection of non-radiated MiaPaCa2 cells ({ p,0.05, t-test). A
nerve score of four indicates normal hind limb function, and a score of one indicates complete paralysis. C. The sciatic nerve index (hindpaw span)
was used as a measure of sciatic nerve function 7 weeks after MiaPaCa2 injection in the right sciatic nerve of mice receiving 0 (control) or 8 Gy of
radiation to the right sciatic nerve prior to injection of non-radiated MiaPaCa2 cells. Radiation to sciatic nerves preserves nerve function in
comparison to non-radiated nerves ({ p,0.05, t-test). D. GDNF production in sciatic nerves decreases 3 weeks after a single radiation dose (8 Gy) as
compared with controls (0 Gy) (p=0.13, t-test).
doi:10.1371/journal.pone.0039925.g005
Radiation Impairs Perineural Invasion
PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e39925Results
In vitro model of nerve invasion by cancer
To investigate dynamic relationships between cancer and
nerves, we developed a co-culture model using an insert divider
as a temporary barrier that is removed to permit the onset of
interactions between cancer cells and DRG within a drop of
Matrigel (Fig. 1A). MiaPaCa2, a pancreatic adenocarcinoma line,
showed a propensity to invade the Matrigel and track along
neurites in a linear, unidirectional manner (Fig. 1A). The amount
of PNI was quantified by measuring the area of cancer cells in
contact with the DRG using MetaMorph software (Fig. 1A). In
contrast, the head and neck squamous cell carcinoma cell line,
QLL2, showed no ability to either invade the Matrigel drop or
associate with neurites (Fig. 1B).
GDNF-mediated cancer cell migration and DRG nerve
invasion
We evaluated the ability of MiaPaCa2 to migrate towards
soluble GDNF or DRG. Non-radiated MiaPaCa2 migrated
towards GDNF, with a slightly stronger migratory behavior
towards DRG (Fig. 1C). The amplified migratory effect by DRG
suggests that nerve-secreted factors other than GDNF may play an
additional role in promoting MiaPaCa2 chemotaxis towards
nerves.
In the DRG-cancer co-culture assay in Matrigel, MiaPaCa2
exhibited an ability to invade the Matrigel and track along neurites
towards the DRG. We found that the addition of anti-GDNF
antibodies reduced the area of PNI by cancer cells as compared
with controls treated with goat IgG (Fig. 1D). These findings
suggest that PNI by MiaPaCa2 in this model is largely mediated
through GDNF.
Single fraction radiation doses and DRG viability
A single radiation dose of up to 20 Gy to DRG resulted in
retained viability, with intact neurite growth and DRG morphol-
ogy (data not shown). However, a single dose of 24 Gy resulted in
death of DRG, with detachment from the Matrigel and loss of
neurites by 4 days after radiation exposure (Fig. 2A). Therefore, a
range of radiation doses up to 16 Gy was selected for use in the
Boyden chamber and DRG-cancer co-culture assays (Fig. 1A) to
ensure that observed effects were not confounded by impaired
DRG viability.
Radiation to DRG alone impairs PNI in vitro
There were no differences observed in the migration of
MiaPaCa2 towards non-radiated or radiated DRG in migration
assays performed over a 24 hour period (data not shown).
However radiation of DRG used in the 8 day DRG-cancer co-
culture assays resulted in a significant decrease in the area of
invasion over an 8 day period. A range of single fraction doses of
Figure 6. Radiation to cancer cells alone diminishes PNI in vivo. A. Representative images of a non-radiated mouse 7 weeks after sciatic nerve
injection with radiated (2 Gy) MiaPaCa2 cells demonstrate intact right hind limb function and diminished gross tumor (*) with normal sciatic nerve
caliber (arrow) in situ, in contrast to non-radiated MiaPaCa2 cells (Fig. 5A). B. Radiation to cancer cells alone prevents sciatic nerve paralysis. Mean
right sciatic nerve function scores were measured 7 weeks after mice underwent sciatic nerve injections with radiated (2 Gy) or control (0 Gy)
MiaPaCa2 cells ({ p,0.05, t-test). C. The sciatic nerve index (hindpaw span) was used as a measure of sciatic nerve function 7 weeks after injection of
radiated (2 Gy) or control (0 Gy) MiaPaCa2 cells into the right sciatic nerve. Mice injected with radiated cancer cells exhibit preserved neurological
function as compared to mice receiving non-radiated control cancer cells ({ p,0.05, t-test). D. Mean gross tumor volumes assessed 7 weeks after
sciatic nerve injections demonstrate that cancer cells receiving radiation (2 Gy) exhibited significantly smaller tumor volumes as compared with
control (0 Gy) cancer cells ({ p,0.05, t-test).
doi:10.1371/journal.pone.0039925.g006
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cancer cells. Non-radiated DRG yielded a mean area of invasion
exceeding 140,000 microns
2. In sharp contrast, DRG radiated
with a single dose of 4–16 Gy yielded mean areas of invasion less
than 14,000 microns
2 (Fig. 2B). No relationship between radiation
dose and area of invasion was identified.
Radiation of DRG decreases GDNF secretion
Conditioned media from radiated DRG was collected 8 days
following radiation exposure and assayed for GDNF. Single-
fraction doses from 4–16 Gy decreased measured GDNF (66 pg/
ml) to undetectable levels as compared with non-radiated DRG
(Fig. 2C). The assay limit of detection was 31 pg/mL.
The reduction of PNI resulting from radiation of DRG was
partially rescued with the direct addition of GDNF to the DRG-
Matrigel complex. Using the DRG-cancer co-culture assays, non-
radiated DRG yielded a mean area of invasion of 170,000 mi-
crons
2, while exposure of DRG to 4 Gy completely inhibited any
measurable area of invasion at day 8. The addition of purified
GDNF to the DRG-Matrigel complex resulted in a partial rescue,
with a mean area of invasion of 73,000 microns
2 (Fig. 2D). The
lack of a full rescue of PNI with GDNF replacement may be
related to the non-physiologic application of the GDNF in these
experiments, an inability to recreate a continuous source of
endogenous GDNF secretion by the DRG, and potential non-
GDNF nerve secreted neurotrophic factors that might be
diminished by radiation.
Radiation of MiaPaCa2 cells impairs migration and PNI
through compromised cellular viability
We evaluated if radiation may impair cancer cell migration and
PNI through mechanisms other than cell death. All experiments
with radiated cells were performed at least 24 hours after radiation
to allow for sub-lethal damage repair. In colony formation assays,
MiaPaCa2 plating efficiency for colony formation was 10%.
Colony formation was susceptible to single-fraction radiation
doses, showing diminishing surviving fractions up through 8 Gy
(Fig. 3A) in a logarithmic fashion.
In migration assays, single fraction radiation of MiaPaCa2
inhibited cancer cell migration towards GDNF and DRG in a
dose-dependent fashion (Fig. 3B). However, these observed
differences correlated directly with surviving cell number in
parallel plate experiments (Fig. 3B), suggesting that the impair-
ment in migration was simply the result of RT-induced
compromised cellular viability, rather than an impairment of
chemotaxis. The assay was then repeated with starting cell
numbers adjusted to achieve equivalent cell viability at 24 hours
for all the radiation doses (data not shown), and differences in
migration towards GDNF and DRG were eliminated.
Radiation exhibited similar effects in the DRG-cancer co-
culture assay over an 8 day period. A single fraction of 2 Gy
significantly decreased the mean area of invasion from
260,000 microns
2 to 54,000 microns
2, with dose response effects
at higher doses (Fig. 3C). However, these decreases in areas of
invasion correlated closely with cell viability as demonstrated by
parallel plate cell counting over the identical time interval (Fig. 3C-
D). These findings again suggest that compromised cellular
viability is the predominant effect of radiation on the cancer cells
in these models, rather than a more specific impairment of
chemotactic function or perineural invasive ability.
Radiation of the sciatic nerve alone diminishes PNI in vivo
To validate in vitro data suggesting that radiation to the nerve
alone may impair PNI, we explored this concept in vivo. For
selected animals, the entire course of a unilateral murine sciatic
nerve was radiated, up to the spinal cord. One week later, non-
radiated MiaPaCa2 cancer cells were injected into surgically
exposed sciatic nerves (Fig. 4A). Mice tolerated single-fraction
Figure 7. RET is expressed widely in human adenoid cystic carcinoma (ACC), which frequently exhibit PNI. A. Hematoxylin-eosin
staining of an ACC specimen (10x) demonstrates well-formed ducts and nests of cells growing in hyalinized stroma in a mixed tubular and cribriform
pattern. RET immunohistochemistry demonstrates widespread staining of ACC at both 10x (B.) and 20x (C.). D. RET immunohistochemistry at 40x
demonstrates 3 cases of PNI, with RET positive expression by ACC cells (arrows) exhibiting PNI of small nerves (*).
doi:10.1371/journal.pone.0039925.g007
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tissue, muscular, or neurological toxicity. Sciatic nerve function
remained normal following single dose radiation up to 16 Gy, and
following the injection of cancer cells.
Mice with non-radiated sciatic nerves injected with non-
radiated MiaPaCa2 cells develop progressive ipsilateral hind limb
paralysis over 7 weeks, with extensive PNI by cancer cells by gross
examination of the nerve (Fig. 4A). The normal murine sciatic
nerve can be visualized in vivo by MRI and histologically (Fig. 4B)
in a normal mouse. Mice with non-radiated sciatic nerves injected
with non-radiated MiaPaCa2 cells underwent MRI at week 7
(Fig. 4B), which demonstrated anatomically thickened sciatic
nerves that are consistent with PNI and histologically show
extensive cancer infiltration along the nerve (Fig. 4B). In contrast,
mice whose nerves were radiated with 4 Gy one week prior to
injection with non-radiated MiaPaCa2 cells exhibited diminished
sciatic nerve invasion by both MRI and histologic assessment
(Fig. 4B).
For a functional assessment of sciatic nerves, mice were
randomized to receive either 8 Gy or no radiation to the sciatic
nerve 1 week prior to injection of non-radiated MiaPaCa2 cells.
The sciatic neurological score (hind limb function) and sciatic
nerve index (hindpaw width) were assessed. Mice receiving 8 Gy to
the nerve showed significantly improved sciatic nerve function in
comparison to mice with non-radiated nerves with impaired
function and paralysis (Fig. 5B, C). Mice were sacrificed at week 7,
and sciatic nerves were excised for gross (Fig. 5A) and histological
assessment.
Radiation of the sciatic nerve alone decreases GDNF
production in vivo
To assess whether radiation alters the production of GDNF
from sciatic nerves following radiation exposure, sciatic nerve
lysates were collected 3 weeks after a single dose of 0 or 8 Gy and
GDNF Elisa performed. A mean GDNF concentration of 130 pg/
ml from non-radiated sciatic nerves was reduced to 65 pg/ml after
a single dose of 8 Gy (Fig. 5D).
Radiation to cancer cells alone diminishes PNI in vivo
Radiation to cancer inhibits PNI in our in vitro models
predominantly through diminished cell viability, rather than
impaired chemotaxis. To assess this concept in vivo, MiaPaCa2
received a single dose of 2 Gy, and 48 hours later were injected
into non-radiated sciatic nerves. Compared with non-radiated
MiaPaCa2 cells, low doses of radiation to the cancer resulted in
diminished invasion on imaging and histopathological analysis at
7 weeks (Fig. 4B). Hind limb function was significantly improved
in animals with radiated MiaPaCa2 cells as compared with
controls (Fig. 6A, B, C, 5A). Tumor volume at 7 weeks was
significantly lower for the radiated MiaPaCa2 cells, compared to
non-radiated MiaPaCa2 control cells (Fig. 6D), suggesting that in
vivo cell viability, proliferation, and tumor progression were
significantly impaired by a single dose of 2 Gy.
Expression of RET in human ACC cancer cells
Radiation is frequently administered to patients with ACC, a
salivary gland cancer, following surgical resection because of its
high propensity for PNI and local recurrence. We assessed
whether patient ACC tumor specimens express RET, the cognate
receptor for GDNF, using immunohistochemical staining. Hema-
toxylin-eosin staining frequently demonstrated well-formed ducts
and nests of cells growing in hyalinized stroma in a mixed tubular
and cribriform pattern (Fig. 7A). We identified mild to moderate
levels of RET expression in all of the 18 human ACC tumor
specimens assessed (Fig. 7B-D). The nerves and surrounding
stromal tissues did not express RET. These findings suggest that
our model of GDNF mediated RET signaling as a mechanism for
chemotaxis and PNI may be clinically relevant for patients with
ACC.
Discussion
To date, there are only limited retrospective reports supporting
the clinical application of radiation for the treatment of cancers
exhibiting PNI. An understanding of how radiation may
mechanistically treat PNI has been lacking. Radiation is
traditionally thought to derive its main clinical benefit in this
capacity by inducing the death of cancer cells present along an
invaded nerve. In the current study, we elucidate a novel
mechanism of how RT may inhibit PNI through the interruption
of paracrine interactions between cancer cells and nerves. We
demonstrate that a single dose of radiation may impair PNI
through not only cancer cell death, but also independent effects on
the nerve itself and the nerve’s production of GDNF, a potent
chemotactic factor.
Recent studies have pointed to the active role that the nerve
microenvironment likely plays in the process of PNI [2,21]. Rather
than being a purely cancer induced event, as it was historically
considered, PNI is now seen as the likely result of reciprocal
interactions occurring between both cancer and nerve elements.
Our group and others have recently demonstrated that PNI may
be facilitated by neural secretion of GDNF, which phosphorylates
the RET tyrosine kinase receptor when coupled with the GFRa
receptor and triggers downstream signaling pathways that
promote cancer cell migration and invasion [16,18,22]. Previous
work from our laboratory demonstrated that DRG from mice
deficient in GDNF (gdnf +/2) had significantly reduced in vitro
invasion compared to wild type mice [18]. Further, we showed
that the pharmacological inhibition of the GDNF-RET signaling
pathway significantly suppressed nerve invasion and prevented
paralysis in mice suggesting that GDNF was relevant in vivo as well
[18].
We report here that radiation may impair PNI through the
combination of independent effects on the cancer and the nerve. A
single dose of radiation to the nerve significantly impaired PNI by
non-radiated cancer cells, both in vitro in a DRG co-culture model
and in vivo in a murine sciatic nerve model. Radiation effects on the
nerve environment may therefore significantly contribute towards
impairing PNI, even in the context of exposure to untreated
cancer cells. Furthermore, we validated that PNI was dependent
on GDNF in vitro, and that GDNF production by nerves was
significantly impaired following radiation exposure in both in vitro
and in vivo models. Other nerve-secreted neurotrophic and
chemokine factors likely play contributing roles in PNI, with
effects that might vary depending on specific cancer cell receptor
expression [2,21]. Further studies will be necessary to elucidate the
potential effects of radiation on a nerve’s production of other
neurotrophic factors. Additionally, while not directly examined in
our current study, nerve secreted ligands may potentially promote
tumor cell survival. Therefore radiation induced suppression of
such ligands may impair PNI through diminished tumor cell
survival independent of the disruption in paracrine signaling and
thereby contribute to some of our experimental findings. This
potential radiation effect is worthy of future study.
As expected, radiation did induce potent direct effects on cancer
cells that were independent of its effects on the nerve microen-
vironment. Experiments were conducted in which radiated cancer
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and these consistently demonstrated a significant inhibition of
migration and PNI. However, correlative cell viability assays
performed in parallel with migration and PNI assays in vitro
suggested that this effect was predominantly the result of
compromised cellular viability, rather than a separate inhibition
of cancer cell chemotactic or neural invasive abilities by the
radiation. Similarly, in vivo tumor formation by radiated cancer
cells was dramatically reduced, pointing to diminished cell viability
and proliferation as the predominant mechanism of activity.
Although the effects of radiation applied to both cancer and nerve
together were not studied, we infer that combination therapy of
both components is likely to be more effective in inhibiting PNI
than of each component individually. In clinical practice, radiation
to a patient with PNI would theoretically be delivered to both
cancer cells and to the nerve microenvironment simultaneously.
The potential clinical relevance of these findings is underscored
by our demonstration of the widespread expression of the GDNF
receptor RET in human ACC specimens exhibiting PNI. High
RET receptor expression has also been found in patients with
pancreatic and prostate carcinomas, which also are known to
exhibit frequent PNI behaviors [23,24]. These findings suggest
that the interruption of the GDNF-RET axis by radiation might
be a clinically relevant strategy for treating PNI for a variety of
cancers with a propensity for this phenotype.
This study has several limitations. First, potential non-GDNF
neurotrophic factors (NGF, BDNF, artemin, CX3CL1, others)
[21] participating in PNI were not explored in this study. Alternate
cancer cell lines with PNI ability and varying cell surface receptor
profiles were also not explored. Although alternate ligand-receptor
interactions likely play a role in PNI mechanisms for other cell
lines, these might be less applicable for MiaPaCa2 cells, where the
GDNF-RET axis likely exerts the predominant effect [18]. Our
deeper focus on MiaPaCa2 was intended to highlight the concept
of radiation’s ability to interrupt a paracrine mechanism of PNI.
This novel idea may be extrapolated to other specific ligand-
receptor systems in the future. A second limitation is that our
studies necessarily separated, for mechanistic clarity, the indepen-
dent effects of radiation on cancer and nerve. In clinical practice
however, radiation is applied to both cancer and nerve simulta-
neously, and we suspect that combination effects might be
enhanced. Other clinical parameters such as identifying optimal
fractionation regimens also may be further evaluated in future
studies.
Understanding the underlying mechanisms through which
radiation may impair PNI is crucial towards improving our
current treatment paradigms for patients with neurotrophic
tumors. Current radiation planning for cancers with PNI involves
designing radiation volumes that encompass the entire longitudi-
nal course of an invaded cranial nerve back to its origin at the base
of the skull, utilizing high doses intended to cause lethal damage to
cancer cells. Such target volumes and associated doses carry the
risk of toxicity due to the close proximity of adjacent critical
structures such as the brain, optic nerves, optic chiasm, cochlea,
and major salivary glands. A greater mechanistic understanding of
PNI, and the effects of radiation on this process, might allow for
optimization of radiation designs.
This study proposes a novel concept: a single low dose of
radiation can impair PNI through not just cancer cell death, but
also through an independent interruption of paracrine mecha-
nisms underlying PNI. These findings suggest that radiation effects
on the nerve microenvironment may derive additional therapeutic
benefits not traditionally appreciated. The radiation doses
considered necessary to inflict cancer cell death may not be
necessary along all sites of the nerve and ganglia to disrupt
neurotrophic signaling. It is possible that further investigation of
this novel concept may ultimately lead to differential delivery of
varying radiation doses along the course of the proximal nerve or
ganglia, towards a goal of paracrine signal disruption rather than
of cancer cell lethality. The ultimate goal of such innovative
targeting strategies would be the enhancement of therapeutic
control of PNI combined with the reduction in radiation induced
toxicity.
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